PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT
申请人:Pellicci PierGiuseppe
公开号:US20100099736A1
公开(公告)日:2010-04-22
The invention discloses the use of a compound of formula (I), wherein R
1
, R
2
, R
3
, and R
4
each independently represents: hydrogen; halo; hydroxy; (C
1
-C
6
) alkyl optionally substituted by hydroxy or (C
1
-C
4
) alkoxy; (C
1
-C
6
) haloalkyl; (C
1
-C
6
) alkoxy; and (C
1
-C
6
) haloalkoxy; for the preparation of a medicament for the prevention and/or treatment of diseases resulting from opening of the MPTP which are characterized by degenerative tissue damages, in particular, diabetes and diabetic complications, neurological diseases and stroke, heart infarction, inherited dystrophies and hepatitis, more particularly, diabetic vascular diseases, such as diabetic retinopathy, and neurodegenerative disorders, such as multiple sclerosis. Further objects are a group of selected individual compounds of formula (I) for use as medicaments and a further group of selected individual compounds of formula (I) as novel compounds.
本发明揭示了使用公式(I)的化合物,其中R1、R2、R3和R4分别独立地表示:氢;卤素;羟基;(C1-C6)烷基,可选地被羟基或(C1-C4)烷氧基取代;(C1-C6)卤代烷基;(C1-C6)烷氧基;以及(C1-C6)卤代烷氧基;用于制备预防和/或治疗由MPTP开放引起的疾病的药物,这些疾病以组织退行性损伤为特征,特别是糖尿病和糖尿病并发症、神经系统疾病和中风、心脏梗塞、遗传性肌营养不良和肝炎,更具体地说,是糖尿病血管病,如糖尿病视网膜病变,以及神经退行性疾病,如多发性硬化症。进一步的目标是一组选择的公式(I)的单个化合物,用作药物,以及一组选择的公式(I)的单个化合物作为新化合物。